New publication:

Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification.

Maurice Zandvliet contributed to this paper together with the Hubrecht institute and the UMCU. Rosemary Millen et al. expose organoids from head and neck cancer to chemo- and radiotherapy and a panel of targeted agents and correlate with patient clinical outcome.